The purpose of this study was to investigate the effects of ovarian hormones on gene expression in the vascular wall. Our approach employed an RT-PCR-based cloning strategy of DNA differential display analysis, and verification/confirmation of differential expression by semi-quantitative PCR and real time PCR. mRNa analysis of normal aortas from intact and ovariectomized female C57BL/6J mice, showed altered expression of 20 genes with significant (> 70 %) sequence homology to known genes. Eight were selected for further study based on the genes' known function and potential relevance to vascular physiology. Differential expression of mRNA for three genes was confirmed by both semi-quantitative and real time RT-PCR using gene-specific primers. Ovariectomy downregulated expression of: elongation factor 1-alpha (3.5-fold), ganglioside-induced differentiation associated protein (8.2-fold), and NADH-ubiquinone oxidoreductase (3.8-fold). Thus, in normal mouse aortas ovariectomy resulted in significant differential down-regulation of a number of vascular genes important to vascular cell growth and angiogenesis, cellular differentiation, and mitochondrial energy metabolism, respectively. These studies have implications for our understanding of hormonal regulation of vascular gene expression, and the therapeutic targeting of specific vascular genetic sequences by female sex steroid hormones.
INTRODUCTION
Female sex steroid hormones have complex and important vasoactive functions that are just now becoming better elucidated. Although the ovaries make a number of androgens (including androstenedione), ovarian steroids, and protein hormones, the actions of the primary ovarian hormones estradiol and estrone have particular cardiovascular significance and have been most extensively characterized. Estrogen is an important female sex steroid hormone with key actions on both physiological and pathophysiological conditions including reproduction, neoplasia, and atherosclerosis. Specifically, increased cardiovascular disease risk, linked to deficiency of female sex steroid hormones, suggest that they may have important vascular actions.
Although the mechanisms by which ovarian steroids affect vascular function are not clear, ovarian hormones are becoming increasingly recognized as complex and powerful cardiovascular mediators (4, 9, 35, 11) . Possible mechanisms by which ovarian hormones, principally estrogen, act on vascular tissue include: enhanced vasodilatation via increased production of nitric oxide, a potent vasodilator (7, 36) ; changes in plasma concentrations of lipids and reductions in vascular cholesterol accumulation (7, 12) and prevention of apoptotic cell death (30, 2) .
In addition, as recently reported (13) , changes in vascular gene expression also occur in response to estrogen. Vasoactive genes known to be estrogen-regulated include: inflammatory mediators such as IL-4 and IL-6 (8, 3) , and adhesion molecules VCAM-1 and ICAM-1 (5, (26) (27) (28) .
In addition, we have demonstrated that the Substance P receptor is upregulated by estrogen (32) .
More recently, using differential display mRNA gene expression profiling of human aortic endothelial cells, our laboratory has reported previously uncharacterized estradiol-sensitive dose and time-dependent up-regulation of three additional genes with potential importance to vascular function: aldose reductase, a caspase homologue, and plasminogen activator inhibitor-1 (33) .
In this report, we extend our recent observations in cultured aortic endothelial cells to examine the effect of loss of ovarian hormones on the genetic profile of the entire vascular wall.
Data from a variety of experimental systems strongly indicate that the loss of ovarian estrogens, as occurs in postmenopausal women and following ovariectomy, is a potent signal for regulation of gene expression (4, 12, 35, 9) . It is therefore highly probable that ovariectomy is an essential trigger for significant genetic reprogramming of the vessel wall. However, this remains a relatively uninvestigated area. The current studies were undertaken in order to establish an initial characterization of changes in gene expression patterns in vessels in response to loss of ovarian sex hormones, and identify specific vascular genetic targets for ovarian hormones.
Based on our previous work, we reasoned that the loss of ovarian hormones would be coupled to a significant genetic reprogramming in the vascular wall of aortas. Experiments were therefore designed using the technique of mRNA gene display (14) to identify differentially expressed genes in response to ovariectomy in normal mouse aortas. This strategy enabled us to identify genes that were selectively induced and/or down-regulated by ovariectomy, and establish relative changes in gene expression levels compared to intact mice. This knowledge is important to advance our current understanding of the profile of genes under hormonal regulation in the vasculature. Following database verification, genes with potential physiological relevance to vascular function were selected for further verification. In order to confirm differential expression of apparently differentially displayed c-DNAs, gene-specific primers were designed and used to amplify the reverse transcription products which were subsequently analyzed by both semiquantitative and real-time RT-PCR.
MATERIALS AND METHODS

Materials
The technique of delta RT-PCR used in these studies is based on reverse transcription and amplification of 3'-terminal RNA sequences (3, 14) . The method relies on a combination of thermophilic DNA polymerases with 3'-5' exonuclease (proofreading) activity to produce larger, easier to detect, higher fidelity, and not overcycled PCR products than possible with conventional PCR (20) . These studies were also designed to minimize false positive results and optimize sensitivity. This technology ensures that differentially expressed genes are more readily identified and cloned than with prior generations of differential display. Specifically, the use of three one-base-anchored oligo-dT primers to subdivide the mRNA population reduces the redundancy and under-representation of the subpopulation of mRNAs (14) . In addition, with built in restriction sites at the 5' ends of both anchored and arbirarry 13mers, the longer primer pairs produce highly selective and reproducible cDNA patterns (34) .
Ovariectomy and Isolation of Mouse Aorta. Eight female C57BL/6J mice were obtained from Charles River (San Diego, CA). Four mice were bilaterally ovariectomized at 6-7 weeks of age and the other four mice left intact. Both sets of mice were kept in as near identical housing conditions as possible controlling for the same environment, food, light and temperature conditions. The ovariectomized mice were allowed to recover for a week and both groups sacrificed 5-6 weeks later using pentobarbital anesthesia (50 mg/kg). Using RNAse-free conditions, the aortas were immediately removed by micro-excision of the entire aorta from the heart to the iliac bifurcation. arbitrary primers used for the RT reactions; see Table 1 for primer sequences. A total of 32 primer pairs were used to amplify the 8 aortic tissue samples. Each primer pair would be expected to yield a different fingerprint and identify a different set of differentially expressed
RNAs, typically 1-2 differential bands per pair. Based on previously published axioms (15), the sixteen arbitrary primers used, combined with each of the three one-base anchored primers, would be expected to detected between 56% -64% of the total aortic mRNAs.
Multiple sequencing gels were prepared and electrophoresed with several replicates of samples from intact and ovariectomized mice. Each replicate consisted of two different DNA samples from intact aortas (control 1 and control 2) loaded adjacent to two different cDNA samples from ovariectomized aortas (ovx 1 and ovx 2). This greately facilitated subsequent screening of the gels and optimized the likelihood of correctly selecting bands that appeared to be differentially displayed by ovariectomy. cDNAsequences were re-amplified in a thermal cycler (Perkin Elmer 2400) based on chance homology to "H-AP" primers following the GenHunter RNAImage protocol using standard PCR techniques (21) . The amplified cDNA subpopulation of mRNAs distributed on DNA sequencing gels was exposed overnight to Kodak
Biomax-MR film.
Identification, Recovery and Reamplification of Apparently Differentially Displayed
cDNAs. Bands demonstrating apparent differential expression by analysis of gel radiographs were identified by two independent observers. Differential display was suggested by the presence of bands in both samples from control aortas and absence in both samples from ovariectomized aortas, or vice versa. An example is provided in Figure 1 . Thus, only transcripts that reproducibly differentially displayed were selected for further analysis. Bands that appeared to be differentially expressed were excised from the gels, then cDNA eluted and reamplified by PCR using the fingerprinting H-T 11 M and H-AP primers. Bands were directly sequenced, cloned, and the clones resequenced.
Cloning and Sequencing of cDNAs. For cloning, the reamplified PCR products were ligated (pCR 2.1-TOPO vector; In Vitrogen) following transformation of One-Shot TOP10F E. Coli competent cells according to the manufacturer's protocol using standard molecular cloning techniques (25) . The PCR product insert was re-amplified using T7 promotor and M13
Reverse primers designed to match the flanking pCR 2.1-TOPO vector sequences to the PCR insert. The thermal cycling parameters were: thermal activation for 8. Sequence data was matched against human and mouse genome databases, including GenBank (http://www.ncbi.nlm.nih.gov/Education/index.html) and the Jackson Laboratory site (www.jackslabs.org), for nucleotide sequences, and against protein and expressed sequence tag (EST) databases using FASTA (FastA) and NetBLAST based on heuristic algorithms (22, 1) . In general, bands that produced direct sequence information and had high homology (> 70%) to known human mRNAs were chosen and pursued for subsequent verification of differential expression.
Semi-quantitative RT-PCR-based verification analysis of differential gene expression.
For 
Real-Time RT-PCR-Based Confirmation Anlaysis Of Differential Gene Expression.
Verification of differential gene expression by semi-quantitative PCR with gene-specific primers is an established approach for analysis of diffential expression (18) . However, the semiquantitative RT-PCR verification experiments used the same template RNA as was used for differential display analysis. Therefore, in order to further confirm differential mRNA expression, a more quantitative approach, real time PCR, was employed. For these studies, two additional mouse aortas (one ovariectomized and one intact) were analyzed. These aortas were not used in the previous differential expression and semi-quantitative PCR verification experiments. However, in order to mitigate against the possible influence of environmental factors on gene expression, care was taken to ensure that the additional aortas were from the same experimental animal cohort as that described earlier in methods.
Briefly, total RNA from the ovariectomized and intact aortas was treated with DNAse 
RESULTS
Differential Display of mRNAs from Ovariectomized and Intact Mouse Aortas.
The differential display autoradiographs yielded over 2,000 gene transcripts that were carefully screened for differential display by two independent observers (see methods). A total of 38 cDNA fragments appared to be differentially displayed by ovariectomy and were subsequently isolated from the gels. Of these, 32 fragments were successfully cloned and sequenced. Fifteen transcripts were apparently up-regulated by ovariectomy (present in aortas of ovariectomized mice but absent in aortas of control intact mice), and 17 transcripts were apparently downregulated by ovariectomy (present in the aortas of intact mice but absent in aortas of ovariectomized mice). Because differential display fingerprinting is not a quantitative tool, but is best utilized as an absent or present screening, it is not possible to categorically state that gene expression for the down-regulated genes was zero following ovariectomy. However, when autoradiographs were viewed by two independent observers, there was no detectable gene expression as demonstrated by complete absence of a visual band.
Following database verification in GenBank, 20 of the apparently differentially displayed bands were found to have significant (greater than or equal to 70%) homology to known genes.
These were considered for further analysis, Table 3 . The remaining 12 genes had lesser degrees of homology to known genes and were therefore not considered for further study. As anticipated from GenBank searches, none of the apparently differentially expressed clones represented novel genes. However, several had short and poor matches to known genes or matches to expressed sequence tags (ESTs) of unknown function, potentially representing novel genes. 
Selection of Genes for Verification of Differential
Verification of the Effect of Ovariectomy on Aortic Differential Gene Expression by SemiQuantitative RT-PCR Analysis. Semi-quantitative RT-PCR identified significant (> two-fold
greater than control) differential expression of mRNAs for 5 of the 8 genes of interest.
Coincidentally, all of the 5 genes were down-regulated by ovariectomy, Table 3 . 
Confirmation of the Effect of Ovariectomy on Differential Aortic Gene Expression by
Real Time RT-PCR Analysis. Table 4 summarizes the mRNA expression ratios for intact:ovariectomized aortas using real time PCR for confirmation of differential expression.
They were as follows: 316-fold for elongation factor 1-alpha (clone 18 f ), 2.2-fold for ganglioside-induced differentiation associated protein (clone 22 a), and 18,000-fold for NADHubiquinone oxidoreductase (clone 34 c). The fold-change for NADH-ubiquinone oxidoreductase (clone 34 c) was unusually large in that this gene had no detectable message in aortas following ovariectomy compared to robust expression in intact aorta. In contrast to the verification studies using semi-quantitative PCR, real time PCR confirmed differential expression for bands 18f, 22a, and 34c. Clones 3b and 5a were determined to not be differential in this analysis, suggesting that real-time PCR may have identified these exceptions as false positives. As expected, the gene tag for GAPDH control showed non-differential expression. Thus, differential expression for the mRNA for three genes-elongation factor 1-alpha, ganglioside-induced differentiation associated protein, and NADH-ubiquinone oxidoreductase, was confirmed to be significantly down-regulated by both semi-quantitative and real time PCR based verification.
DISCUSSION
In order to gain insight into the actions of ovarian hormones in genetic regulation of the vascular wall, we performed mRNA differential display analysis to identify genes differentially regulated by ovarian sex steroids in murine aortas. In so doing, we have demonstrated the utility of differential display as a molecular screen to profile genes that are differentially expressed by loss of ovarian steroids in vascular tissue, and identified vascular genes whose expression was not previously known to be significantly modulated by ovariectomy. In the systematic screening performed in this study, 20 genes with significant sequence homology to known genes demonstrated apparent differential display following ovariectomy. Eight genes were selected for verification of differential expression based on the gene's physiological relevance to cardiovascular function. Three genes were subsequently verified and confirmed to have significant differential expression in aortas; all were down-regulated by ovariectomy when compared to the intact animals: elongation factor 1-alpha, ganglioside-induced differentiation associated protein, and NADH-ubiquinone oxidoreductase. These genes encode a host of proteins with seemingly divergent functions suggesting a link between loss of ovarian function and angiogenesis, cell growth and differentiation, and mitochondrial energy metabolism, respectively.
The elongation factor-1 alpha (EF-1alpha) family of polypeptides, one of the differentially displayed genes identified to be down-regulated in our study, promote polypeptide chain elongation during mRNA translation. EF-1alpha is a ubiquitously expressed important component of the protein synthesis apparatus in eukaryotic tissues (10) . EF-1alpha is also involved in vascular endothelial cell sprouting and elongation in vitro, as well as the formation of networks of elongated endothelial cells (17) . Therefore, down-regulation of EF-1alpha by ovariectomy could be important in retarding angiogenesis.
The second gene identified to be down-regulated by ovariectomy in this study was the In non-vascular animal systems ovariectomy has been previously associated with changes in the expression of genes with primary relevance to hormonal actions. For example, in rats ovariectomy is associated with a progressive increase in mRNA levels for alpha 2,3-STase, one of the enzymes that incorporates sialic acid residues into follicle stimulating hormone (FSH), and an important regulator of FSH isoforms and estrogen output (4). However, ovariectomy has also been demonstrated to be associated with changes in expression of genes pertinent to vascular physiology. For example, mRNA expression for steroid hormone receptors was demonstrated to decrease after ovariectomy in aortic and venous rat vessels (11) . Furthermore, in ovariectomized female pigs, expression of mRNA for both the endothelial isoform of nitric oxide synthase (eNOS) and endothelin-1, two important vasoactive peptides, is increased when compared to their expression in intact female pigs (31) . Interestingly, in humans, expression of the P450c5 gene, the key enzyme involved in the conversion of progestins to androgens, demonstrates significant variation in levels of expression in postmenopausal ovaries compared to normal cycling ovaries, without significant differences in the overall gene expression levels between the two states (9) . Therefore, the assumption that loss of ovarian hormones inevitably results in changes in gene expression in all systems needs to be challenged and specifically tested.
The most plausible mechanism by which ovariectomy could regulate gene expression in the blood vessel wall is by ovarian steroid-stimulated regulation of mRNA transcription.
However, in other systems, changes in gene expression may be a consequence of mRNA breakdown (19) . Therefore, it is possible that ovariectomy could affect both the transcriptional rate of the genes identified and/or the stability of their mRNAs. Although our study was not designed to tease out these processes, the data presented provide significant new information about vascular targets for hormone action and lay the foundation for additional future mechanistic work in this area.
In this study, only genes whose sequences are found in GenBank were investigated, yielding information on regulation of known genes by loss of ovarian steroids. It would be interesting as a next step to embark on the discovery of unknown genes regulated by ovariectomy. Novel genes may be represented by EST fragments that are in GenBank, yet have no known function or characterization. In addition, poor matches to GenBank nucleotide sequences also could be novel genes. In fact, some of the ovariectomy-regulated sequences found by this study corresponded to ESTs in the human genome database with unknown function or poor matches to known genes; perhaps some of these ESTs are to novel genes. Although those ESTs were not further characterized, cloning them would be of future interest.
The bipartite differential display technique utilized for these studies, consisting of (i) RT-PCR and electrophoresis followed by (ii) gene identification and verification, takes advantage of new inovations designed to improve reliability and reduce false positives in differential display.
For example, the methodology improves on previous approaches to differential display by:
subdividing the mRNA population in three, built in restriction sites at the 5' ends of both anchored and arbitrary primers, longer PCR primers, loading of samples in duplicate, and the use of two approaches to verify and confirm differentially expressed cDNAs. However, our study has certain limitations: The techniques, although reliable in identifying differentially expressed gene products, do not provide a functional assessment of the differentially expressed genes identified. It is also possible that some of the lower sequence homology genes (< 80%) may represent mismatches. Furthermore, ovariectomy could have varying effects on vascular gene expression at differing times following ovariectomy and at different phases of the reproductive cycle. This would not be revealed by the present studies as we studied mice at one point in time.
An additional limitation is that loss of ovarian steroids, hormones, and peptides following ovariectomy does not permit inferences to be made about the role of specific ovarian hormones (e.g., estrogen), or ovarian vasoactive peptides (e.g., vascular endothelial growth factor and relaxin), on regulation of gene expression. Rather, our studies are an important first step towards this analysis. Lastly, our studies do not localize gene expression changes in the vessel wall.
Given that the aorta is a complex tissue consisting of several cell types (endothelial cells, smooth muscle cells and adventitia), gene expression could clearly vary by cell type relative to cell function. Nonetheless, our studies provide novel data in this evolving area of science, lay new groundwork for further research in this area, and add to our understanding of the molecular basis for female sex steroid hormone action in the vasculature.
In summary, the results of our studies serve to extend the findings of prior studies in three ways. First, we've demonstrated that ovariectomy is associated with significant changes in vascular gene expression in the vessel wall. Second, we've identified three vascular genes previously unreported to be regulated by ovarian hormones that may act as genetic targets for hormone action. And third, in our analysis we've broadened the spectrum of gene functions potentially regulated by ovarian steroids in the vasculature.
In conclusion, the genes differentially regulated by ovariectomy identified in the present study have not previously been identified to be under the control of ovarian hormones. These For each of the five specific genes of interest (clones 3a, 5a, 18f, 22a, and 34c), the mean densitometry signal ratio of intact:OVX was significantly greater (> 2.0) in intact compared to ovariectomized aortas confirming down-regulation of expression by ovariectomy. 
